Goyette P., Sumner J.S., Milos R., Duncan A.M., Rosenblatt D.S., Matthews R.G., and Rozen R., 1994. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification.
Grosveld E., 1999. Activation by locus control regions?
Hagberg B.. Aicardi J., Dias K., and Ramos O., 1983. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: Report of 35 cases.
Hagerman P.J. and Hagerman R.J., 2004. The fragile-X premutation: A maturing perspective.
Hagerman R.J., Van Housen K., Smith A.C., and McGavran L., 1984. Consideration of connective tissue dysfunction in the fragile X syndrome.
Handa V., Saha T., and Usdin K., 2003. The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer.
Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes CM., and Gartler S.M., 1999. The
Harikrishnan K.N., Chow M.Z., Baker E.K., Pal S., Bassal S., Bra-sacchio D., Wang L.. Craig J.M., Jones PL., Sif S., and El-Osta A., 2005. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.
Hark A.T., Schoenherr C.J., Katz D.J., Ingram R.S., Levorse J.M., andTilghman S.M., 2000. CTCF mediates methylation-sensitive enhancer-blocking activity at the
Harrison C.J., Jack E.M., Allen T.D., and Harris R., 1983. The fragile X: A scanning electron microscope study. /.
Hasegawa T., Hara M., Ando M., Osawa M., Fukuyama Y., Taka-hashi M., and Yamada K., 1984. Cytogenetic studies of familial Prader-Willi syndrome.
Hayward B.E., Kamiya M., Strain L., Moran V., Campbell R., Hayashizaki Y, and Bonthron D.T., 1998. The human
Henry I., Bonaiti-Pellie C., Chehensse V., Beldjord C, Schwartz C, Utermann G., and Junien C., 1991. Uniparental paternal disomy in a genetic cancer-predisposing syndrome.
Hoal-van Helden E.G. and van Helden P.D., 1989. Age-related methylation changes in DNA may reflect the proliferative pc -tential of organs.
Horike S., Cai S., Miyano M., Cheng J.F., and Kohwi-ShigematsuT., 2005. Loss of silent-chromatin looping and impaired imprinting of
Hubbard VS., Davis P.B., di Sant’Agnese PA., Gorden P., and Schwartz R.H., 1980. Isolated growth hormone deficiency and cystic fibrosis: A report of two cases.
Ingrosso D., Cimmino A., Pema A.F., Masella L., De Santo N.G., De Bonis M.L., Vacca M., D’Esposito M., D’Urso M., Galletti P., and Zappia V., 2003. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomo-cysteinaemia in patients with uraemia.
Ishizuka A., Siomi M.C., and Siomi H., 2002. A
Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., and Baylin S.B., 1994. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.
Jeanpierre M., Turleau C., Aurias A., Prieur M., Ledeist E., Fischer A., and Viegas-Pequignot E., 1993. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome.
Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele C., Sweatt J. D., and Beaudet A. L., 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation (see comments).
Jin P., Alisch R.S., and Warren S.T., 2004a. RNA and microRNAs in fragile X mental retardation.
Jin P., Zamescu D.C., Zhang E., Pearson C.E., Lucchesi J.C., Moses K., and Warren S.T., 2003. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in